Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Baars

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|August 18, 2001
Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancerJ G Schrama, J W Baars, M J Holtkamp, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Renal cell carcinoma and interleukin-2: a reviewJ Wagstaff, J W Baars, G J Wolbink, et al.
European Journal of Applied Physiology and Occupational Physiology|January 1, 1993
Determination of capillary leakage due to recombinant interleukin-2 by means of noninvasive conductivity measurementsC G Olthof, J W Baars, J Wagstaff, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 30, 2008
Propofol extravasation in a breast cancer patientE J M Huijbers, J W Baars, P F E Schutte, et al.
Experimental Hematology|May 20, 1998
A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplantsJ Kwekkeboom, D E Buurman, R E Ploemacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2)J W Baars, J Wagstaff, C E Hack, et al.
Immunopharmacology|September 1, 1992
Interplay of complement and cytokines in the pathogenesis of septic shockJ P de Boer, G J Wolbink, L G Thijs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepaS Rodenhuis, J W Baars, J H Schornagel, et al.
Human Antibodies|May 12, 2011
The pharmacokinetics of ¹³¹I-rituximab in a patient with CD20 positive non-Hodgkin Lymphoma: evaluation of the effect of radioiodination on the biological properties of rituximabL Tran, J W Baars, J P de Boer, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 30, 1993
[Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy]D J Richel, J W Baars, M J Wijngaarden, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|August 18, 2001
Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancerJ G Schrama, J W Baars, M J Holtkamp, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Renal cell carcinoma and interleukin-2: a reviewJ Wagstaff, J W Baars, G J Wolbink, et al.
European Journal of Applied Physiology and Occupational Physiology|January 1, 1993
Determination of capillary leakage due to recombinant interleukin-2 by means of noninvasive conductivity measurementsC G Olthof, J W Baars, J Wagstaff, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 30, 2008
Propofol extravasation in a breast cancer patientE J M Huijbers, J W Baars, P F E Schutte, et al.
Experimental Hematology|May 20, 1998
A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplantsJ Kwekkeboom, D E Buurman, R E Ploemacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2)J W Baars, J Wagstaff, C E Hack, et al.
Immunopharmacology|September 1, 1992
Interplay of complement and cytokines in the pathogenesis of septic shockJ P de Boer, G J Wolbink, L G Thijs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepaS Rodenhuis, J W Baars, J H Schornagel, et al.
Human Antibodies|May 12, 2011
The pharmacokinetics of ¹³¹I-rituximab in a patient with CD20 positive non-Hodgkin Lymphoma: evaluation of the effect of radioiodination on the biological properties of rituximabL Tran, J W Baars, J P de Boer, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 30, 1993
[Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy]D J Richel, J W Baars, M J Wijngaarden, et al.
Pageof 6